Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Moy

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy StatementKaren M Winkfield, Jonathan K Phillips, Steven Joffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2019
Expanding Access to Cancer Clinical Trials for Patients With Mental IllnessKelly E Irwin, Beverly Moy, Lauren E Fields, et al.
Clinical Breast Cancer|October 11, 2022
Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness ModelNathaniel Hendrix, Nina Oestreicher, Deepa Lalla, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 19, 2023
Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved PopulationsGiselle K Perez, Anjali R Oberoi, Lucy Finkelstein-Fox, et al.
JCO Oncology Practice|June 6, 2022
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial ParticipantsSubha Perni, Chukwuma Azoba, Emily Gorton, et al.
Breast Cancer Research and Treatment|September 22, 2022
Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancerAnne Marie McCarthy, Alisa K Manning, Sarah Hsu, et al.
JAMA|October 18, 2007
Institutional academic industry relationshipsEric G Campbell, Joel S Weissman, Susan Ehringhaus, et al.
NPJ Breast Cancer|April 19, 2023
Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancerNeelima Vidula, Andrzej Niemierko, Katherine Hesler, et al.
BMC Medical Informatics and Decision Making|August 22, 2014
Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapyClara N Lee, Matthew H Wetschler, Yuchiao Chang, et al.
The Oncologist|April 17, 2019
Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity InterventionRyan D Nipp, Hang Lee, Emily Gorton, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2018
Addressing Financial Barriers to Patient Participation in Clinical Trials: ASCO Policy StatementKaren M Winkfield, Jonathan K Phillips, Steven Joffe, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2019
Expanding Access to Cancer Clinical Trials for Patients With Mental IllnessKelly E Irwin, Beverly Moy, Lauren E Fields, et al.
Clinical Breast Cancer|October 11, 2022
Residual Disease Burden After Neoadjuvant Therapy Among US Patients With High-Risk HER2-positive Early-Stage Breast Cancer: A Population Effectiveness ModelNathaniel Hendrix, Nina Oestreicher, Deepa Lalla, et al.
Cancer Control : Journal of the Moffitt Cancer Center|September 19, 2023
Qualitative study of Oncology Clinicians' Perceptions of Barriers to Offering Clinical Trials to Underserved PopulationsGiselle K Perez, Anjali R Oberoi, Lucy Finkelstein-Fox, et al.
JCO Oncology Practice|June 6, 2022
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial ParticipantsSubha Perni, Chukwuma Azoba, Emily Gorton, et al.
Breast Cancer Research and Treatment|September 22, 2022
Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancerAnne Marie McCarthy, Alisa K Manning, Sarah Hsu, et al.
JAMA|October 18, 2007
Institutional academic industry relationshipsEric G Campbell, Joel S Weissman, Susan Ehringhaus, et al.
NPJ Breast Cancer|April 19, 2023
Utilizing cell-free DNA to predict risk of developing brain metastases in patients with metastatic breast cancerNeelima Vidula, Andrzej Niemierko, Katherine Hesler, et al.
BMC Medical Informatics and Decision Making|August 22, 2014
Measuring decision quality: psychometric evaluation of a new instrument for breast cancer chemotherapyClara N Lee, Matthew H Wetschler, Yuchiao Chang, et al.
The Oncologist|April 17, 2019
Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity InterventionRyan D Nipp, Hang Lee, Emily Gorton, et al.
Pageof 17